Goodenough was formerly senior account manager at Cohn & Wolfe, working for the last five years in its London and New York offices, and jointly managing the policy team.
Goodenough reports to comms director Jason Browning and will be the contact for Just PR, which won the business this year (PRWeek, 11 April). Brands include Diovan, Exforge and Rasilez (hypertension), a pre-licence product whose generic name is vildigliptin (diabetes) and Exelon (for Alzheimer’s).
Novartis is currently mounting a legal challenge against the National Institute for Health and Clinical Excellence’s decision to limit the prescribing of Alzheimer’s drugs including Exelon.
Novartis has restructured its comms in the past 18 months and recruitment is continuing. It includes a comms manager for corporate activities.